causal
Process Expertise Creates Moats Beyond Pills
Complex therapies like CAR Ts and personalized gene therapies require high-touch process expertise and scale that are far beyond traditional pharma's model of making a pill in a factory, and this complexity lets companies build distribution moats.
causalpending
Speaker
AlexEvidence Quote
“So these complex therapies are one way of pharmas trying to build up moats to distribution of products.”
Source
Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the BestCreated: 11/14/2026, 6:42:06 AM
Your notes
Loading notes...